Healthy Dialogue

Latest Episodes:

A Continued Focus on Equity Through Pharmacoequity and Digital Health Equity: Two Current Viewpoints Oct 22, 2021

Show notes

Individuals who experience systemic, structural, institutional, and social barriers within society deserve better and more convenient health care access. This idea should be central when advancing efforts to achieve health equity. JAMA Editorial Board member Raina M. Merchant, MD, speaks with Courtney R. Lyles, PhD, and Urmimala Sarkar, MD, about approaches toward improving digital health equity and with Utibe R. Essien, MD, about enhancing targeted efforts toward realizing pharmacoequity.

Related Content:

Administrative Costs in US Health Care: A Quarter-Trillion-Dollar Opportunity Oct 20, 2021

Show notes

Health care expenses that arise from largely nonclinical functions, such as coding and billing and administration, cost the US health care system almost $1 trillion annually. Michael Chernew, PhD, from Harvard Medical School Department of Health Care Policy, and David Cutler, PhD, from Harvard University Department of Economics, join JAMA Associate Editor Karen Joynt Maddox, MD, MPH, from Washington University School of Medicine to discuss some basic fixes and simplifications that could reduce administrative spending by an estimated $265 billion.

Related Content:

Effect of Carbon Dioxide Laser vs Sham Therapy on Women With Postmenopausal Vaginal Symptoms Oct 12, 2021

Show notes

Interview with Jason A. Abbott, and Fiona G Li, authors of Effect of Fractional Carbon Dioxide Laser vs Sham Treatment on Symptom Severity in Women With Postmenopausal Vaginal Symptoms: A Randomized Clinical Trial

Scopolamine Butylbromide for Preventing End-of-Life Death Rattle Oct 05, 2021

Show notes

Death rattle, defined as noisy breathing caused by the presence of mucus in the respiratory tract, is common among dying patients. Harriette van Esch, MD, from the Erasmus Medical Center, the Netherlands, and Jared R. Lowe, MD, from the University of North Carolina, join JAMA Associate Editor Ethan Basch, MD, to discuss evidence about use of prophylactic scopolamine butylbromide to reduce the death rattle.

Related Content:

Effect of Prophylactic Subcutaneous Scopolamine Butylbromide on Death Rattle

Preventing Death Rattle With Prophylactic Subcutaneous Scopolamine Butylbromide

COVID-19 in Canada—Experience and Response to Waves 2 and 3 Sep 28, 2021

Show notes

Canadian law gives the country's individual provinces and territories primary responsibility for coronavirus containment and mitigation. JAMA Associate Editor Preeti Malani, MD, MSJ, from the University of Michigan and Allan S. Detsky, MD, PhD, from the University of Toronto, Ontario, Canada, discuss the national pandemic experience, including public health responses to infection and vaccine allocation, from fall 2020 through summer 2021.

Related Content:

COVID-19 in Canada: Experience and Response to Waves 2 and 3

USPSTF Recommendation: Aspirin Use to Prevent Preeclampsia and Related Morbidity and Mortality Sep 28, 2021

Show notes

Interview with Aaron B. Caughey, MD, USPSTF member and coauthor of Aspirin Use to Prevent Preeclampsia and Related Morbidity and Mortality: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force

Related Content:

USPSTF Recommendation: Screening for Chlamydia and Gonorrhea Sep 14, 2021

Show notes

Interview with Martha Kubik, PhD, RN, USPSTF member and coauthor of Screening for Chlamydia and Gonorrhea: US Preventive Services Task Force Recommendation Statement

Addressing Diversity, Equity, and Inclusion in Health Care and Medicine Aug 17, 2021

Show notes

While health disparities have gained growing attention in recent years, much work is still needed, as inequities continue to have a direct and measurable negative influence on patients in historically disadvantaged communities. David Satcher, MD, PhD, Francisco Cigarroa, MD, and Howard Koh, MD, MPH, join moderator Ebony Boulware, MD, MPH, to discuss the vital importance of the visibility of all races and ethnicities in research, medical schools, and health care. They propose potential solutions, including the recruitment of and support for more physicians who look like their patients, who care enough, know enough, have the courage to make a difference, and who will persevere until changes are made.

Related Content:

Noninvasive Ventilation of COVID-19 Patients Mar 29, 2021

Show notes

Noninvasive ventilation (NIV) may help COVID-19 patients in respiratory failure avoid invasive mechanical ventilation but may also lead to delays in intubation with potential for worse clinical outcomes.

Domenico L. Grieco, MD, of Fondazione Policlinico Agostino Gemelli IRCCS in Rome, Jesse B. Hall, MD, of the University of Chicago, and Laveena Munshi, MD, MSc, of Sinai Health System/University Health Network of the University of Toronto join JAMA's live Q&A series to discuss helmet NIV, high-flow nasal oxygen, and other NIV modalities in the management of hypoxic coronavirus patients. Recorded March 25, 2021.

Respiratory Support During the COVID-19 Pandemic: Is It Time to Consider Using a Helmet?

Noninvasive Ventilation of COVID-19 Patients

Precision Dosing—A Clinical and Public Health Imperative Mar 24, 2021

Show notes

Interview with Kimberly Maxfield, PhD, author of Precision Dosing—A Clinical and Public Health Imperative

Our TOPPODCAST Picks

Follow Us

Stay Connected

Related Podcasts

Links

Stay Connected